Introduction
The E5 genes of papillomaviruses encode short hydrophobic polypeptides, many of which have been shown to have transforming activity. They vary in length from just over 40 (bovine) to 90 or more (human) amino acids, of which the Nterminal two-thirds are highly hydrophobic and span the membrane bilayer. E5 expression gives rise to anchorageindependent growth and, in some instances, to focus formation as well (DiMaio et al., 1986 ; Schiller et al., 1986 ; Horwitz et al., 1988 ; Bergman et al., 1988 ; Leptak et al., 1991 ; Pennie et al., 1993) . A similar hydrophobic polypeptide is encoded by the p12h ORF of human T-lymphotropic virus (HTLV) type I and it too has weak transforming properties (Franchini et al., 1993) .
Many of the E5 proteins have been found to bind growth factor receptors (Goldstein et al., 1994 ; Hwang et al., 1995 ; Petti & DiMaio, 1994) . Bovine papillomavirus (BPV) type 1 E5 binds the platelet-derived growth factor receptor, whilst human papillomavirus (HPV) type 16 E5 binds epidermal growth factor receptor and both E5 proteins activate their respective receptors (Petti et al., 1991 ; Pim et al., 1992 ; Leechanachai et al., 1992) . Likewise, p12h binds the interleukin-2 receptor (Mulloy et al., 1996) . Expression of E5 proteins in cultured cells often leads to decreased receptor cycling (Martin et al., 1989) . So, although there is little sequence similarity across the E5 proteins, it would seem that they have a common mode of action.
Supporting this conclusion is the finding that all E5 proteins so far examined (BPV-1 E5, BPV-4 E5, HPV-6 E5, HPV-16 E5 and HTLV-I p12h) bind to the 16 kDa subunit c proteolipid of the vacuolar H + -ATPase (V-ATPase) Conrad et al., 1993 ; Franchini et al., 1993 ; Faccini et al., 1996) . This multi-subunit enzyme is an essential proton pump of eukaryotes and is responsible for the low pH of many endomembrane compartments including Golgi, secretory vesicles, endosomes and lysosomes . The possible disturbance of V-ATPase activity has been suggested to account for the effects on growth factor receptor cycling .
Subunit c is also the ' ductin ' component of a type of gap junction, an intercellular complex that provides sites of cell-tocell movement for low-molecular-mass solutes . Connexins also form gap junction channels, and mutant forms of ductin that have transforming ability disturb connexin localization and down-regulate gap junction communication (Saito et al., 1998) . Several E5 proteins have also been shown to down-regulate gap junction communication (Oelze et al., 1995 ; Faccini et al., 1996 ; Ashrafi et al., 2000) . However, a recent mutational study on one E5 protein, BPV-4 E5 (previously designated E8), dissociates this down-regulation from anchorage-independence (Ashrafi et al., 2000) .
This suggests that the common target of E5 proteins is the V-ATPase form of subunit c. Consistent with this are the observations that HPV-16 E5 retards the acidification of early endosomes (Straight et al., 1995) and that BPV-1 E5 elevates the pH of the Golgi (Schapiro et al., 2000) . Two recent studies (Adam et al., 2000 ; Briggs et al., 2001 ) also suggest a substantial impairment of the V-ATPase in Saccharomyces cerevisiae on expression of HPV-16 E5. Expression of BPV-4 E5 also results in large clusters of perinuclear vesicles, often incompletely separated, indicating endomembrane dysfunction (Ashrafi et al., 2000) . In this context, a recent study (Peters et al., 2001) has shown that the V ! domain may act in the later stages of membrane fusion and that subunit c may be part of the transient fusion-pore complex.
We have therefore investigated the effect of high levels of expression of E5 proteins on the V-ATPase. We chose S. cerevisiae for this study, as the yeast form of V-ATPase is similar in composition to higher eukaryotic forms and is not essential for viability under normal growth conditions, whereas loss of V-ATPase in higher eukaryotes is lethal. In contrast to the studies of Adam et al. (2000) and Briggs et al. (2001) , we find that, although all E5 transforming proteins examined bind to Vma3p (the S. cerevisiae form of subunit c), they do not impair V-ATPase activity in any measurable way, unlike a dominant-negative form of subunit c, which inactivates the enzyme. At least one of them, HPV-16 E5, becomes dissociated from the active V-ATPase. In a compromised hybrid form of the V-ATPase containing Norway lobster subunit c, which is also known to bind all E5 proteins so far examined, there is no apparent disturbance of the V-ATPase. These results indicate that disturbance of vacuolar compartments by E5 transforming proteins is a secondary effect. A reason for the binding of E5 transforming proteins in terms of the mechanism of action of the V-ATPase is discussed.
Methods
Yeast strains. The following yeast strains were used : YPH 500 (MATα ura3 lys2 ade2 trp1 his3 leu2) (a gift from Y. Anraku, Dept of Biological Sciences, University of Tokyo, Japan) and W303-1B vat c (MATα ura3 lys2 ade2 trp1 his3 leu2 LEU2 ::vma3) (a gift from N. Nelson, Dept of Biochemistry, Tel Aviv University, Israel). Cultures were maintained in complete (YPD) or minimal (YNB) medium with appropriate nutrient supplements (Sherman, 1991) . Media were buffered to pH 5n5 with 50 mM succinate or to pH 7n5 with MES\MOPS.
Plasmids. Plasmid pPMA was used for expression of the E5 proteins and Vma3p E137G. The inserted gene is under the control of the plasma membrane H + -ATPase promoter. pPMA is a 2 µ-based plasmid and contains the selectable marker URA3. A modified form of the pYES2 plasmid (Invitrogen) was used for the expression of the Norway lobster subunit c tagged at the C terminus with hexahistidine (Harrison et al., 1994) . The URA3 gene had been replaced by the TRP1 gene (Hughes et al., 1996) . Expression of the inserted gene in the pYES2 vector is under control of the GAL4 promoter.
Antibodies. Monoclonal antibodies (MAbs) to the V-ATPase components subunit A (Vma1p) and Vph1p and to the epitopes HA1 and AU1 were purchased from Cambridge Bioscience. The rabbit polyclonal antibody to Norway lobster subunit c has been described previously (Leitch & Finbow, 1990) .
Oligonucleotides. The construction of BPV-4 E5 and variant forms has been described elsewhere (O'Brien et al., 1999 ; Ashrafi et al., 2000) . Coding sequences of BPV-1 E5 (a gift from R. Schlegel, Dept of Pathology, Georgetown University, Washington, DC, USA), HTLV-I p12h (a gift from G. Franchini, NIH, Bethesda, MD, USA) and HPV-16 E5 (a gift from A. Alonso, Deutsche Krebforschungszentrum, Heidelberg, Germany) were amplified by PCR (PfuTurbo ; Stratagene) with oligonucleotides incorporating BamHI and KpnI restriction sites and an epitope tag to the HA1 antigen. These allowed ligation of the PCR product directly into the BamHI site of the pPMA vector and determination of orientation by KpnI restriction digestion. The BPV-1 E5 5h oligonucleotide was shorter because the template already contained the HA1 tag.
The primers used were : for HA1-BPV-1 E5 ; 5h GCGGGATCCA-TGCCAAATCTATACCCATACG 3h and 3h GCGGGATCCGGTA-CC TTAAAAGGGCAGACCTGT ACAG 5h ; for HA1-HTLV-I p12h, 5h GGGATCCGCCGCCACCATGTACCCATACGATGTTCCAGA-TTACGCTCTGTTTCGCCTTCTCAGCCC 3hand 3h GGGATCCCG-GTACCCTAGAAGAGGAAAGCCGCGG 5h ; for HA1-HPV-16 E5, 5h GGCGGATCCTGC CGCCACCATGTACCC ATACGATGTTCCA-GATTAC GCTACAAATCTT GATACTGCA 3h and 3h GGCGGA-TCCGGTACCTATTTATGTAATTAAAAAGCGTGC 5h. All cloned PCR products were sequenced and found to be the same as published sequences.
The dominant-negative ductin (Vma3p) construct was made in two stages. The first stage added the HA1 epitope tag and PstI and XhoI restriction sites to allow directional cloning into pCRscript (Stratagene). The second stage mutated glutamate-137 to glycine and the final product was blunt-end ligated into pPMA and sequenced to check the mutation and the integrity of the insert. The successive pairs of oligonucleotides were as follows, with the mutated nucleotide underlined : HA1-Vma3p, 5h GGGCTGCAGATGACTGAATTGTGTCCTGTC 3h and 3h GGG-CTCGAGTTAAGCGTAGTCTGGAACATCGTATGGGTAACAG-ACAACATCTTGAGTA GCC 5h ; Vma3p E137G, 5h GATTTTGAT-TTTGATTTTTGCTGGAGTTTTGGGTCTATACGGTTT 3h and 3h AAACCGTATAGACCCAAAACTCCAGCAAAAATCAAAATC-AAAATC 5h.
DNA templates for in vitro translation were synthesized by PCR using oligonucleotides that included the T7 RNA polymerase promoter, to allow T7-mediated transcription, and a ' Kozak ' sequence to ensure efficient translation of the RNA product. The HA1-T7-KOZAK oligonucleotide primed onto the HA tag sequence, so it was also used for all of the E5 proteins except BPV-1 E5. All products were generated from pPMA constructs, allowing the universal 3h oligonucleotide PMArev to be used, which was also used for sequencing the constructs.
Primer sequences were : Vma3p E137G-T7-KOZAK, 5h AAATA-ATACGACTCACTATAGGGAGAGCCACCATGACTGAATTGTG-TCCTGTC 3h ; HA1-BPV-1 E5-T7-KOZAK, 5h AAATAATACG-ACTCACTATAGGGAGAGCCACCATGCCAAATCTATACCCAT-ACG 3h; HA1-T7-KOZAK, 5h AAATAATACGACTCACTATAG-GGAGAGCCACCATGTACCCATACGATGTTCCAG 3h ; PMArev, 3h GGGAAGTAAGAGTTGAAGCC 5h.
Vacuole isolation.
Vacuoles were isolated by a method based on that of Uchida et al. (1985) . Yeast cultures (200 ml) were grown in minimal medium overnight at 30 mC to an OD '!! of 0n5-1. Sugar (glucose or galactose\raffinose) was added to restore the concentration to 2 % (w\v), 2 h before the cells were harvested by centrifugation at 5000 g for 5 min at room temperature. The cells were then washed in 20 ml phosphate buffer (50 mM Na # HPO % \NaH # PO % , pH 7n5) and spheroplasts were prepared by re-suspending in 20 ml digest buffer [1 M sorbitol, phosphate buffer, pH 7n5, 2 % (w\v) glucose or galactose\ raffinose, 0n4% (v\v) β-mercaptoethanol, 0n5 mg\ml yeast lytic enzyme (ICN Biochemicals ; 70 000 units\g)] and incubating at room temperature for 1 h. The spheroplasts were harvested at 2000 g for 5 min at room temperature under a cushion of 1n2 M sorbitol in the same buffer. All subsequent steps were carried out at 4 mC. The spheroplasts were resuspended in 6 ml floatation buffer [8 % (w\v) Ficoll 400, 10 mM MES-Tris pH 6n9, 0n5 mM MgCl # ], containing the protease inhibitors 4-(2-aminoethyl)-benzenesulphonylfluoride (AEBSF ; 0n1 mM) and benzamidine (1 mM) (both from Sigma-Aldrich). Spheroplasts were then lysed by four strokes in a loose-fitting homogenizer and the suspension was poured into a Beckman SW40 thin-walled polyallomer tube, overlaid with floatation buffer and centrifuged at 51 900 g for 30 min. The layer of vacuoles was harvested with a spatula from the top of the tube and resuspended in 1n5 ml buffer C (10 mM MES-Tris pH 6n9, 5 mM MgCl # , 25 mM KCl, 0n1 mM AEBSF, 1 mM benzamidine). The vacuoles were harvested by centrifugation at 20 000 g for 5 min, re-suspended to approximately 2 mg\ml in buffer C and either used immediately or stored at k70 mC in buffer C containing 10 % (w\v) glycerol.
Measurement of protein content. Protein content was measured by using the bicinchoninic acid (BCA) method. BCA reagent (SigmaAldrich) was prepared fresh according the manufacturer's instructions. Samples were solubilized in 0n1% (w\v) SDS and the reaction mixture was incubated at 65 mC for 30 min. Absorbance at 562 nm was measured and the protein concentration was calculated from a standard curve of BSA.
Purification of the V-ATPase by glycerol gradient centrifugation. This was adapted from the method of Uchida et al. (1985) for a benchtop ultracentrifuge. Vacuoles (1 mg protein) were washed twice in TE (10 mM Tris-HCl, pH 7n5, 1 mM EDTA) by centrifugation at 400 000 g max for 10 min at 4 mC. The final pellet was re-suspended in the residual buffer, to which was added 50 µl 10% (w\v) N-dodecyl maltoside solution and 5 µl yeast protease inhibitor cocktail (SigmaAldrich). The solution was mixed by slow pipetting and then incubated at 4 mC for 15 min to solubilize the membrane proteins. Insoluble material was removed by centrifugation at 400 000 g for 10 min at 4 mC and the supernatant was loaded onto 2 ml of a 10-step density gradient [20-50 % (w\v) glycerol, 10 mM HEPES-NaOH, pH 7n5, 50 mM NaCl, 0n01 % (v\v) yeast protease inhibitor cocktail]. Centrifugation was carried out in a TLS-55 swing-out rotor at 200 000 g for 5 h at 4 mC using minimum acceleration and deceleration. Fractions (200 µl) were collected into a 96-well plate by upward displacement using fluorinert (3M).
Measurement of V-ATPase activity.
Reactions contained 200 µl buffer C [plus 0n02 % (w\v) sodium azide] and 5 µl vacuoles (10 µg protein). Ethanol (5 µl) (with or without 5 mg\ml NhN-dicyclohexylcarbodiimide ; DCCD) was added to the reactions, which were mixed briefly by vortexing and then incubated at room temperature for 5 min. ATP (30 µl ; 50 mM in buffer C) was added to all reactions, which were then mixed by vortexing and incubated at 30 mC for 30 min. The reaction was terminated by addition of 750 µl phosphate detection reagent [2 % (v\v) sulphuric acid, 1 % (w\v) SDS, 0n5% (w\v) ammonium molybdate, 0n1% (w\v) ascorbic acid]. The absorbance at 830 nm was measured after 10 min and phosphate concentrations were determined from a standard curve of sodium phosphate.
For the microplate assay of the purified V-ATPase, 50 µl buffer C containing 5 mM ATP and 0n02 % (w\v) sodium azide was added to 5-30 µl aliquots from the gradient fractions. The reactions were mixed, incubated at 30 mC for 30 min and developed using 100 µl doublestrength phosphate detection reagent and the absorbance was measured at 630 nm against a standard curve of sodium phosphate. Kinetic analysis was performed in the same way, using 1-2 µg vacuoles per well, as described in Harrison et al. (1994) . For determination of Nethylmaleimide-(NEM ; Sigma-Aldrich) sensitive ATPase activity, NEM was added to 100 µM for 5 min before the addition of ATP.
In vitro synthesis and immunoprecipitation. In vitro synthesis in the presence of microsomal membranes and immunoprecipitation were carried out as described previously (Dunlop et al., 1995 ; Faccini et al., 1996 ; Ashrafi et al., 2000 ; Rodriguez et al., 2000) .
Protein preparation, SDS-PAGE and autoradiography. Four vols acetone-ethanol (1 : 1) was added to vacuoles and the mixture was vortexed before being cooled at k20 mC for 30 min. The protein was collected by centrifugation at 20 000 g for 30 min and the supernatant was removed before re-suspending the protein in SDS loading buffer [50 mM Tris-HCl, pH 6n8, 5 % (w\v) glycerol, 2n5% (w\v) SDS, 0n1% (w\v) bromophenol blue]. 15 % Tris-Tricine polyacrylamide gels were used to optimize the resolution of the E5 proteins. The gel was fixed in 50 % methanol-10 % acetic acid (v\v) for 1 h, dried onto Whatman paper and exposed to X-ray film (Fuji super RX) for approximately 1 week.
Immunoblotting and dot blotting. Proteins were transferred from SDS-PAGE gels to Hybond nitrocellulose membrane (Amersham Pharmacia) using a semi-dry blotting apparatus. The transfer buffer contained 100 mM Tris base, 100 mM glycine, 0n1 % SDS and 20 % (v\v) methanol. Methanol was not included for immunoblotting of E5 proteins or Vma3p E137G. The membranes were blocked with commercial skimmed milk powder in 10 mM Tris-HCl (pH 7n5), 50 mM NaCl and 0n01 % (w\v) Tween for 30 min and incubated overnight with the appropriate antibody (1 : 500 dilution) after rinsing four times in the above buffer. Bound antibody was detected using the ECL detection system (Amersham Pharmacia). For dot blotting, 10 µg aliquots of vacuolar protein samples were precipitated in acetone-ethanol as described above, solubilized in SDS loading buffer and spotted directly onto nitrocellulose membrane. The samples were allowed to dry completely before blocking and processing as for immunoblots.
Results

Binding of E5 proteins to S. cerevisiae Vma3p
A previous study (Goldstein et al., 1992 b) showed that BPV-1 E5 binds to Schizosaccharomyces pombe Vma3p, the subunit c proteolipid of the V-ATPase. As there is high sequence similarity both between these two and to other subunit c proteolipids (e.g. 85 % identity between fungal, human and bovine forms in the transmembrane domains), it seems likely that S. cerevisiae Vma3p will bind E5 proteins. We therefore examined the binding of S. cerevisiae Vma3p in an in vitro binding assay. We have shown previously, using this assay, the specificity of interaction and the requirement for interacting proteins to be located in a membrane environment (Dunlop et al., 1995) . For example, BPV-1 E5 does not bind the Vma3p-related yeast protein Vma16p and truncated forms of HPV-16 E5 do not bind the Norway lobster subunit c, but fulllength HPV-16 E5 does (Faccini et al., 1996 ; Rodriguez et al., 2000) . Included in this study were the following E5 proteins : BPV-1 E5A, HPV-16 E5, HTLV-I p12h, BPV-4 E5 and three mutant forms, N17A, N17S and ∆Cterm, in the last of which, the 12 Cterminal residues have been removed. BPV-4 E5 N17A has hypertransforming activity, while BPV-4 E5 ∆Cterm has lost transformation ability (O'Brien et al., 1999) . All the E5 proteins were tagged at their N termini with the HA1 epitope. Vma3p was tagged with the AU1 epitope at its C terminus. RNAs were translated in the presence of microsomes derived from pancreatic endoplasmic reticulum and pelleted microsomes were used for immunoprecipitation after solubilization.
Immunoprecipitation with MAbs to AU1 brought down Vma3p, as expected, but not any of the E5 proteins (Fig. 1 a, b) , when the RNAs were translated separately. However, when the RNAs for the E5 proteins were translated together with the RNA for Vma3p, E5 proteins were also precipitated. Varying amounts of the E5 proteins were seen, and we therefore repeated these experiments but precipitating with MAbs to the HA1 epitope (Fig. 1 c) . As expected, this antibody did not precipitate Vma3p in separate translations but, when cotranslated with E5 proteins, Vma3p was present in the immunoprecipitate.
In later expression experiments (see below), we also used Norway lobster subunit c. All E5 proteins used in this study have been shown to bind this form of subunit c (Faccini et al., 1996 ; Ashrafi et al., 2000 ; Rodriguez et al., 2000) , with the exception of HTLV-I p12h. We therefore carried out a similar experiment using AU1-tagged p12h. Again, immunoprecipitating with anti-AU1 antibodies or with antiserum 650 (a rabbit polyclonal antiserum to Norway lobster subunit c) resulted in both proteins being precipitated (Fig. 1 d) .
Expression of E5 transforming proteins in S. cerevisiae
We used the vector pPMA, in which expression of the inserted gene is constitutive, for expression of the E5 transforming proteins. This vector was chosen because a previous study had shown that expression was much higher than that from galactose-inducible promoters (e.g. GAL4), to the extent that even deleterious mutant forms of subunit c could be detected on immunoblots of vacuolar membranes. As a positive control to show that we could inactivate the V-ATPase by expression from this vector, we prepared a mutant form of Vma3p in which residue E137 had been changed to glycine (Vma3p E137G). This residue is crucial for proton pumping and we have shown previously that such a mutant can act as a dominant negative (Hughes et al., 1996) . As with the viral proteins, Vma3p E137G was tagged with the HA1 epitope, but at its C terminus. The YPH500 haploid strain of S. cerevisiae was used, a strain that has been used by others to examine the V-ATPase (Umemoto et al., 1991) . YPH500 cells were transfected with the various pPMA vector constructs and RT-PCR analysis confirmed the expression of the inserted genes (data not shown). Vacuoles were isolated from transfected cells and examined for the presence of the appropriate protein by probing immunoblots or dot blots with MAbs to the HA1 epitope.
Immunoblots from vacuoles showed the presence of HPV-16 E5 and Vma3p E137G migrating at their expected sizes ( 2 a). There were also aggregated forms of HPV-16 E5, which were not broken down to monomeric species by reducing agents. However, the other E5 proteins could not be detected, even though a number of different membranes and blotting conditions were tried. Presumably, the smaller size of the proteins, notably those derived from BPVs, and their high hydrophobicity makes their detection difficult. We therefore used dot blots, drying the solubilized vacuolar membranes directly on to the support membrane. By this approach, all E5 proteins were found to be present (Fig. 2 b) . Measurement of the exponential growth rates of these strains in liquid minimal medium plus appropriate supplements showed no effect. Cells expressing any of the E5 proteins had doubling times similar to that of control cells (2n6 h). However, cells expressing Vma3p E137G had an increased doubling time of 5n6 h, close to the doubling time (6n4 h) of the vat c strain, in which the VMA3 gene has been disrupted.
Effects on V-ATPase-dependent growth
Growth of YPH500 under normal culture conditions (pH 5n5 and low extracellular calcium) is not dependent upon an active V-ATPase. However, at pH 7n5 or in the presence of 100 mM calcium, growth is dependent upon an active VATPase. We therefore examined the growth of the transfected YPH500 cells under restrictive growth conditions. Fig. 3 . Growth of YPH500 cells expressing E5 proteins under restrictive conditions. The various YPH500 transformants and vat c cells were grown for 3 days at 30 mC in YPD medium buffered to pH 5n5 or pH 7n5 or in the presence of 100 mM CaCl 2 with either glucose or galactose/raffinose as the carbohydrate source. All transformants grew at pH 5n5, and vat c cells and YPH500 cells expressing Vma3p E137G gave white colonies, whilst the other transformants gave red colonies. None of the E5 transforming proteins affected viability at pH 7n5 or in high extracellular calcium. Segments of the plates (see diagram) contained the following combinations : 1, YPH500jpPMA ; 2, vat cjpPMA ; 3, YPH500jVma3p E137G ; 4, YPH500jBPV-1 E5 ; 5, YPH500jHTLV-I p12h ; 6, YPH500jHPV-16 E5 ; 7, YPH500jBPV-4 E5 ; 8, YPH500jBPV-4 E5 N17S ; 9, YPH500jBPV-4 E5 N17A ; 10, YPH500jBPV-4 E5 ∆Cterm.
Transformed cells were grown on complete medium plates with glucose as the major nutrient source at pH 5n5 or 7n5 or with 100 mM calcium. As controls, YPH500 and VMA3-knockout cells were transfected with an empty pPMA vector. The VMA3-knockout strain was vat c, derived from W303-1B, used in previous studies (Harrison et al., 1994 (Harrison et al., , 1999 (Harrison et al., , 2000 Jones et al., 1995) .
Cells of strains vat c and YPH500 expressing Vma3p E137G failed to grow at pH 7n5, whilst all others transfectants grew (Fig. 3) . There was weak growth of the Vma3p E137G mutant in 100 mM calcium, however. In addition, vat c cells and Vma3p E137G cells formed white colonies, consistent with the loss of V-ATPase activity. Both parental strains are ade2 − and therefore give rise to red colonies in the presence of an active V-ATPase (Umemoto et al., 1991) . These results showed that none of the E5 proteins, whether transforming or not, appeared to inactivate the V-ATPase and that this was unlikely to be due to poor expression from the pPMA vector. The same results were also obtained if the transfectants were grown on selective minimal medium (lacking uracil) to maintain the pPMA vector (data not shown).
The V-ATPase of S. cerevisiae is also known to be sensitive to the nutrient source. For example, switching from glucose to galactose causes the almost total loss of V-ATPase activity, and activity only recovers to approximately 40 % after galactose adaptation (Parra & Kane, 1998) . We therefore examined growth on a galactose-based medium and, as expected, growth was slower. However, none of the E5 proteins affected the viability of the transfectants to grow at either pH 7n5 or in 100 mM calcium. Consistent with the poorer growth rate, the residual growth on glucose seen with Vma3p E137G on 100 mM calcium was suppressed when the cells were grown on galactose.
Effects on V-ATPase activity and ATP hydrolysis
Growth under restricted conditions occurs at low levels of V-ATPase activity or when the enzyme has been partially disabled. For example, replacing Vma3p with the Norway lobster subunit c tagged with a hexahistidine tail at its C terminus still rescues growth at pH 7n5, but elevates the K m for ATP hydrolysis tenfold relative to the native enzyme (Harrison et al., 1994) . We therefore measured the V-ATPase activity in isolated vacuoles and the K m for ATP hydrolysis.
Vacuoles were isolated from exponentially growing cultures and the ATPase activity was measured in the presence of azide to remove any contamination by mitochondria. VATPase activity is inhibited by the fungal macrolide bafilomycin and by NEM and DCCD, in all cases giving a 70 % loss of total ATPase activity. Vacuoles isolated from vat c cells have residual ATPase activity. As DCCD is known to react uniquely with the critical glutamic acid on the fourth α-helix of subunit c (E137 of Vma3p ; Finbow et al., 1992) and this residue has been identified as the site of binding of BPV-1 E5 (Andresson et al., 1995) , we measured the DCCD-inhibitable ATPase activity.
The results show that none of the E5 proteins affected the level of V-ATPase activity (Fig. 4) . In contrast, V-ATPase activity in the Vma3p E137G mutant was reduced by over 90 % and is similar to a level of ATPase activity found in vacuoles isolated from the vat c strain. We also measured the V-ATPase activity in vacuoles isolated from cells expressing the untagged, wild-type form of HPV-16 E5 (data not shown) but, again, there was no impairment of the V-ATPase, indicating that the N-terminal tag does not interfere.
V-ATPase activity is reduced by 60 % when the cells are grown with galactose\raffinose medium but, again, there was no quantitative impairment by the E5 proteins. The lack of a quantitative effect on ATPase activity attributable to the VATPase was mirrored by the absence of any qualitative effect on the enzyme, as the K m and V max for ATP hydrolysis remained unaffected ( Fig. 5 ; V max data not shown). The VATPase activity and the K m for ATP hydrolysis are similar to values reported for the yeast enzyme (Harrison et al., 1994) .
Dissociation of HPV-16 E5 from the V-ATPase
Whilst the E5 proteins are present in the yeast vacuole, it is possible that they do not remain associated with the active VATPase. We therefore solubilized the vacuoles in a non-ionic Fig. 4 . E5 transforming proteins do not affect V-ATPase activity. Vacuoles were isolated and V-ATPase activity was measured with DCCD as an inhibitor. None of the E5 transforming proteins affected ATPase activity attributable to the V-ATPase, but Vma3p E137G reduced V-ATPase activity to a level comparable to that of the vat c strain, which carries the VMA3 gene inactivation. Galactose reduced V-ATPase activity considerably, by around 60 %, but, again, the E5 transforming proteins did not reduce this activity further. Error bars show SEM. detergent and separated the V-ATPase on glycerol gradients by ultracentrifugation. Fractions were collected and the ATPase activity was measured, in this case with NEM as the inhibitor. Immunoblots from the fractions were probed with the anti-HA1 antibody and with MAbs to Vma1p (a V " component) and Vph1p (a V ! component). The peak NEM-inhibitable ATPase activity coincided with the presence of V-ATPase subunits (Fig. 6) . However, HPV-16 E5 was found in lighter fractions and did not overlap with the V-ATPase.
Effects of E5 proteins on a disabled enzyme in poor nutrient conditions
As mentioned already, Norway lobster subunit c tagged at the C terminus with hexahistidine (N subunit c-his ' ) rescues growth of vat c cells at pH 7n5 but has a high K m for ATP. We transfected vat c cells with the pYES2 vector containing the cDNA for N subunit c-his '
, which rescued V-ATPase activity to the level reported previously (Harrison et al., 1994) . However, transfecting these vat c cells with the empty pPMA vector was sufficient, in some unexplained way, perhaps due to nutrient demands, to reduce V-ATPase activity to a residual level, although there was still growth at pH 7n5. As all E5 proteins examined so far (see above) are known to bind the Norway lobster subunit c, we examined the effects of the E5 proteins in the doubly transfected vat c cells.
As expected, the cultures took longer to grow and, again, whilst Vma3p E137G blocked the rescue of growth at pH 7n5 by N subunit c-his ' , none of the E5 proteins did (Fig. 7) . Examination of glycerol gradients showed assembled V- 1 and 4) , N subunit c-his 6 and Vma3p E137G tagged with HA1 (lanes 2 and 5) or N subunit c-his 6 and HPV-16 E5-HA1 (lanes 3 and 6). Membranes (100 µg) were solubilized in 0n5 ml RIPA buffer (Faccini et al., 1996) and, after pelleting non-solubilized material (400 000 g for 10 min at 4 mC), the supernatant was passed down a nickel-agarose column (Sigma) and washed with RIPA and increasing concentrations of imidazole buffer according to the manufacturer's instructions. The final elution was in 100 mM imidazole buffer and immunoblots of the eluate were prepared and probed with antiserum 650 (N subunit c ; lanes 1-3) or anti-HA1 antibodies (HPV-16 E5 and Vma3p E137G ; lanes 4-6).
ATPase present in fractions similar to those for the wild-type enzyme, but HPV-16 E5, whilst now having a broader distribution, overlapped little (Fig. 8 a) . We also probed for the N subunit c-his ' using a polyclonal rabbit antibody and its distribution overlapped with HPV-16 E5 and Vma1p, indicating that there may still be binding between these two polypeptides. We therefore examined possible binding between HPV-16 E5 and N subunit c-his ' using nickel-affinity columns to bind the hexahistidine tails. Eluates of highly stringent washes from these columns indicated the presence in the vacuole of complexes of HPV-16 E5 and N subunit c-his ' (Fig. 8 b) .
Discussion
A common property of all E5 proteins examined so far is their ability to bind the bovine and Norway lobster forms of the V-ATPase 16 kDa proteolipid subunit c. Our study extends this, showing that these E5 proteins also bind the S. cerevisiae form, Vma3p. Given the high conservation of subunit c, particularly in the transmembrane region, and the earlier observation of binding of BPV-1 E5 to S. pombe Vma3p (Goldstein et al., 1992 b) , this result is not unexpected. Results from other studies indicate that this binding is specific (Faccini et al., 1996 ; Ashrafi et al., 2000 ; Rodriguez et al., 2000) . For example, there is no detectable binding between C-terminally truncated forms of HPV-16 E5 and subunit c, yet these forms are similar in size and hydrophobicity to BPV-1 E5 and BPV-4 E5 (Rodriguez et al., 2000 ; Adam et al., 2000) .
Given the specificity of binding, it would be expected that the E5 transforming proteins would affect the functions of subunit c complexes such as the V-ATPase. Several studies indicate that this might be the case. For example, HPV-16 E5 appears to delay the acidification of the early endosome (Straight et al., 1995) , whilst BPV-1 E5 and BPV-4 E5 both appear to elevate Golgi pH (Schapiro et al., 2000 ; M. S. Campo and R. Schlegel, unpublished results) . Also, HPV-16 E5 and various mutant forms decrease the exponential growth rate of S. cerevisiae at pH 7n5 when present at high levels (Adam et al., 2000) , indicating impairment of the V-ATPase.
Our study shows that none of the E5 proteins, whether capable of transformation or not, perturbs V-ATPase activity in any detectable way, even when a compromised subunit c is used under poor growth conditions. In addition, at least one of these proteins, HPV-16 E5, is not part of the active V-ATPase, although it can remain bound to subunit c complexes within the vacuolar membrane. It is not clear why we found no disturbance of the V-ATPase in S. cerevisiae whilst Adam et al. (2000) and Briggs et al. (2001) found that HPV-16 E5 and many mutant forms impaired growth at pH 7n5 and appeared to destabilize the V-ATPase. However, not all mutants of HPV-16 E5 that bind subunit c impaired growth at the restrictive pH, indicating that other factors may have come into play in these two studies.
If E5 proteins bind specifically to subunit c, why do they not remain attached to the active V-ATPase ? There are two possibilities. Firstly, Vma12p and Vma22p of S. cerevisiae are not dissimilar to the E5 transforming proteins, being short, highly hydrophobic polypeptides (Graham et al., 1998) . They are essential assembly factors of V ! , but are not present in the holoenzyme and are presumably lost during maturation or targeting of the enzyme. A similar situation might also occur for E5 proteins. Secondly, the proposed rotation of the subunit c core driven by ATP hydrolysis past the Vph1p ' stator ' may physically dislodge E5 proteins. Recent structural data (Pa! li et al., 1999 ; Harrison et al., 1999 Harrison et al., , 2000 on the arrangement of subunit c shows helix 4 to be outermost, facing the bilayer, and this helix forms part of the binding region with BPV-1 E5 and HPV-16 E5 Adam et al., 2000) , notably the key glutamic acid residue. Thus, E5 transforming proteins are likely to be attached peripherally to V ! , rather than being integrated within the complex. In addition, recent work on the related F ! subunit c (Rastogi & Girvin, 1999) predicts that much of the BPV-1 E5 binding domain on the V ! subunit c may undergo a substantial conformational change during proton translocation and be transiently re-located within the interior of V ! . A number of recent mutational studies (Adam et al., 2000 ; Ashrafi et al., 2000 ; Rodriguez et al., 2000) show that the ability of E5 proteins to bind subunit c does not correlate with their transforming activity. The biological significance of this interaction is therefore unclear. One possibility is a chaperone function. Tagging BPV-1 E5 with an endoplasmic reticulum retention signal results in the inability to transform, indicating that the site of action of this transforming polypeptide lies outside the endoplasmic reticulum . Binding to subunit c may therefore provide an export mechanism for E5 transforming proteins to the Golgi and postGolgi compartments. Once in the Golgi, when the V-ATPase is first activated, E5 proteins may become dissociated to bind to other targets, e.g. growth factor receptors.
Another explanation for binding of E5 proteins to subunit c relates to the recent finding that apposing V ! sectors form inter-membrane complexes during late stages of vesicle fusion (Peters et al., 2001) , possibly being the ' fusion pore ' observed a number of years ago in exocytosis (Breckenridge & Almers, 1987 ; Finbow et al., 1991) . Such a possibility might account for the profusion of vesicles in fibroblasts expressing E5 proteins. Coincidentally, these vesicles are ' coupled ' to one another, as shown by the transfer of the gap junction-permeant tracer dye Lucifer yellow, indicating stalled fusion events.
